Related Articles
Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death
DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells
N1‑guanyl‑1, 7‑diaminoheptane enhances the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine via the inhibition of eukaryotic translation initiation factor 5A2
Pancreatic cancer with liver metastasis maintaining complete response with gemcitabine monotherapy: A case report
Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer